SCHEMBL1506495

SCHEMBL1506495

C=C(C)C(=O)OC(C)(C)C.Oc1ccc(C=CC=Cc2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.42
CYP3A4 P08684 3/20 0.41
MIF P14174 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
MAOB P27338 3/20 0.40
HSPD1 P10809 2/20 0.40
HSPE1 P61604 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
PKM P14618 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH2 P05091 1/20 0.40
CYP19A1 P11511 1/20 0.40
F3 P13726 1/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL7711595 0.95 CYP3A4 (0.41) APPCYP3A4MIFABCG2MAOB
SCHEMBL2708850 0.90 CCNB2 (0.47) CYP3A4MAOBKMT2AMAPTMEN1
SCHEMBL5438375 0.89 MAPT (0.44) APPCYP3A4MIFMAOBMAPT
SCHEMBL5453451 0.88 APP (0.39) APPCYP3A4ABCG2MAOBHSPD1
SCHEMBL5433795 0.88 CYP1A2 (0.44) APPMIFKMT2AMAPTRAB9A
SCHEMBL2707109 0.88 KMT2A (0.41) CYP3A4MAOBHSPD1HSPE1KMT2A
SCHEMBL5454879 0.88 MMP1 (0.42) APPMIFMAOBRELAMAOA
SCHEMBL2706218 0.88 CYP3A4 (0.41) CYP3A4MIFMAOBHSPD1HSPE1
4-Vinylphenol SCHEMBL7711559 0.88 MIF (0.42) CYP3A4MIFABCG2MAOBHSPD1
4-Vinylphenol SCHEMBL7711593 0.88 MIF (0.42) CYP3A4MIFABCG2MAOBHSPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1059563-B1 Agent for reducing substrate dependence of resist WAKO PURE CHEM IND LTD (JP) 2006-08-09 EP claimed
US-6586152-B1 Useful as an ingredient of a resist composition used for preparation of semiconductor devices and the like, which comprises a compound shown by the following general formula useful as an ingredient of a resist composition used for WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2003-07-01 US claimed
EP-1059563-A1 Agent for reducing substrate dependence of resist Wako Pure Chemical Industries, Ltd. (JP) 2000-12-13 EP claimed
EP-2447291-B1 HIGH-MOLECULAR-WEIGHT COPOLYMER NIPPON SODA CO (JP) 2015-04-08 EP disclosed
US-8729187-B2 High-molecular-weight copolymer NIPPON SODA CO., LTD. (JP) 2014-05-20 US disclosed
US-20120123076-A1 HIGH-MOLECULAR-WEIGHT COPOLYMER NIPPON SODA CO., LTD (JP) 2012-05-17 US disclosed
EP-2447291-A1 HIGH-MOLECULAR-WEIGHT COPOLYMER Nippon Soda Co., Ltd. (JP) 2012-05-02 EP disclosed
US-8158326-B2 Photosensitive composition, compound for use in the photosensitive composition, and method of pattern formation with the photosensitive composition FUJIFILM CORPORATION (JP) 2012-04-17 US disclosed
US-7914965-B2 Resist composition and method of pattern formation with the same FUJIFILM CORPORATION (JP) 2011-03-29 US disclosed
EP-1449833-B1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION WAKO PURE CHEM IND LTD (JP) 2009-09-09 EP disclosed
US-20090075202-A1 PHOTOSENSITIVE COMPOSITION, COMPOUND FOR USE IN THE PHOTOSENSITIVE COMPOSITION, AND METHOD OF PATTERN FORMATION WITH THE PHOTOSENSITIVE COMPOSITION FUJIFILM CORPORATION (JP) 2009-03-19 US disclosed
US-20060068320-A1 Resist composition and method of pattern formation with the same FUJI PHOTO FILM CO., LTD. 2006-03-30 US disclosed
US-20060040203-A1 Photosensitive composition, compound for use in the photosensitive composition, and method of pattern formation with the photosensitive composition FUJI PHOTO FILM CO., LTD. 2006-02-23 US disclosed
US-6949329-B2 Pattern formation method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-09-27 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
US-20040170918-A1 Poly(p-hydroxystyrene/styrene/alkyl acrylate) terpolymer derivative and acid generator comprising triphenylsulfonium benzenesulfonate derivative; forming positive pattern using transcription technology in high vacuum with irradiated energy such as electron beam, extreme ultraviolet ray and X-ray WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2004-09-02 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed
US-6586152-B1 Useful as an ingredient of a resist composition used for preparation of semiconductor devices and the like, which comprises a compound shown by the following general formula useful as an ingredient of a resist composition used for WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2003-07-01 US disclosed
US-20030017425-A1 Pattern formation method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2003-01-23 US disclosed
EP-1059563-A1 Agent for reducing substrate dependence of resist Wako Pure Chemical Industries, Ltd. (JP) 2000-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 APP 928/4885CYP3A4 2399/4885MIF 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.